We recently published 10 Small Caps With Big Double-Digit Gains. Lithium Americas Corp. (NYSE:LAC) is one of the top performers of last week. Lithium Americas surged by 18.78 percent week-on-week, as investors positioned portfolios amid the surging prices of lithium. Latest data from Trading Economics showed that prices of lithium jumped by 18.45 percent in November, and by 0.48 percent to $93,750 on Friday alone. The overall optimism spilled over Lithium Americas Corp. (NYSE:LAC), owner of the Thacker ...

We recently published 10 Small Caps With Big Double-Digit Gains. Northern Dynasty Minerals Ltd. (NYSEAmerican:NAK) is one of the top performers of last week. Northern Dynasty Minerals climbed by 28 percent week-on-week, as investors placed bets on copper and gold miners amid the surge in prices of the said metals. Last Friday alone, gold spot increased by 1.97 percent to $4,239 per troy ounce while copper was up by 2.28 percent at $11,189 per metric ton, as traders set sights on precious metals ahead of ...

Jensen Huang is not shy about addressing popular investor opinion.The CEO made comments in response to investors who believe the market for AI stocks is in a bubble.*Stock prices used were the afternoon prices of Nov. 27, 2025. The video was published on Nov. 29, 2025. ...

Centuri Holdings Inc. (NYSE:CTRI) is one of the best new stocks to invest in. On November 19, Centuri Holdings announced that it had completed the acquisition of Connect Atlantic Utility Services Corporation/CAUS, Atlantic Canada’s leading electric utility services provider. The acquisition immediately establishes Centuri as a dual electric and gas services provider in Canada, complementing the gas distribution services already provided by its current Canadian subsidiary. The company operates primarily in ...

Group 1 - Bristol-Myers Squibb Company (NYSE:BMY) is recognized as one of the 15 Best Boring Dividend Stocks to Buy, indicating its stable dividend profile despite limited growth [1] - The company is experiencing a lack of significant growth but remains profitable, with a payout ratio of approximately 84%, which is considered sustainable given its free cash flow of $15.3 billion over the past 12 months, significantly exceeding the $5 billion paid in dividends [3] - Concerns exist regarding the long-term sustainability of dividends due to the company's net debt of $32 billion, although this is a reduction from $38.5 billion at the beginning of the year [4] Group 2 - Positive Phase 3 trial results for Bayer's FXIa inhibitor asundexian have drawn attention to the FXIa drug class, potentially increasing interest in similar treatments from Bristol-Myers Squibb and Johnson & Johnson, although Morgan Stanley remains cautious on BMY despite initial stock gains [2]

Core Insights - Mondelez International, Inc. (NASDAQ:MDLZ) is recognized as one of the 15 Best Boring Dividend Stocks to Buy, indicating its stable dividend performance and investment appeal [1] Financial Performance - For Q3 2025, Mondelez reported revenue of $9.74 billion, reflecting a 5.9% increase year-over-year [3] - Year-to-date, the company generated $2.1 billion in operating cash flow and $1.2 billion in free cash flow [3] - In the first nine months of the year, Mondelez returned $3.7 billion to shareholders [3] Market Challenges - CEO Dirk Van de Put noted ongoing challenges in the European market, despite a solid chocolate business [4] - The company faces pressure in certain areas due to competitors not raising prices as much as Mondelez, and retailers capturing a larger share of the margin in some markets [4] Analyst Updates - Piper Sandler lowered its price target for Mondelez to $62 from $63 while maintaining a Neutral rating, reflecting updates in models due to GLP-1 news, increased ABV headwinds, and tariff relief [2]

Core Insights - Gilead Sciences, Inc. (NASDAQ:GILD) is recognized as one of the 15 Best Boring Dividend Stocks to Buy, indicating a stable investment opportunity in the dividend space [1] - Truist initiated coverage of Gilead with a Buy rating and a price target of $140, citing the strength of its HIV portfolio and promising next-generation programs as key factors for a positive long-term outlook [2] - The company's HIV treatment Biktarvy generated $3.7 billion in sales, reflecting a 6% increase year-over-year, while Descovy's revenue rose 20% to $701 million, showcasing robust performance in its core business [3] - Gilead's liver disease treatments also contributed to growth, with sales increasing 12% year-over-year to $819 million, supporting the company's diversification strategy [4] Business Performance - Gilead's underlying business remains solid, with a focus on broadening its portfolio beyond the HIV segment to reduce dependence on it over time [4] - The ongoing strength of the HIV franchise and advancements in oncology efforts are viewed as significant drivers for future growth [2][3]

Core Insights - Chubb Limited (NYSE:CB) is recognized as one of the 15 Best Boring Dividend Stocks to Buy [1] - Morgan Stanley raised its price target for Chubb to $300 from $295, indicating a stable outlook despite a softening property and casualty market [2] - Chubb's insurance operations are resilient against economic downturns, with a combined ratio of 86.6%, significantly better than the industry average of 96.6% [3] Dividend and Shareholder Returns - Chubb announced a quarterly dividend of $0.97 per share, maintaining consistency with previous payouts, and has increased its dividend for 32 consecutive years [4] - In Q3 2025, Chubb returned $1.62 billion to shareholders, which included $1.23 billion in share repurchases at an average price of $277.67 per share and $385 million in dividends [4] Company Overview - Chubb operates as a global insurer, providing a wide range of commercial and personal property and casualty coverage, as well as accident, health, and life insurance [5]

Primo Brands Corporation (NYSE:PRMB) is among the best US stocks to buy under $20. On November 25, Bonnie Herzog, an analyst at Goldman Sachs, trimmed the price target on Primo Brands Corporation (NYSE:PRMB) to $18 from $21, while maintaining a Neutral stance on the stock, according to TheFly. In a research note, the analyst raised concerns regarding the sales decline, which she believes will be faster and more prolonged than anticipated. With respect to that, the firm expects incremental headwinds for the ...

StubHub Holdings, Inc. (NYSE:STUB) is among the best US stocks to buy under $20. As of November 26, StubHub Holdings, Inc. (NYSE:STUB) is a strong Buy, with around two-thirds of analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $25, the stock has an upside of over 126%. According to TheFly, BofA downgraded StubHub Holdings, Inc. (NYSE:STUB) to Neutral from Buy on November 14, with a reduced price target of $19 from $25. The revised price target, whic ...